Literature DB >> 33152557

The multifaceted roles of microRNAs in differentiation.

Himani Galagali1, John K Kim2.   

Abstract

MicroRNAs (miRNAs) are major drivers of cell fate specification and differentiation. The post-transcriptional regulation of key molecular factors by microRNAs contributes to the progression of embryonic and postembryonic development in several organisms. Following the discovery of lin-4 and let-7 in Caenorhabditis elegans and bantam microRNAs in Drosophila melanogaster, microRNAs have emerged as orchestrators of cellular differentiation and developmental timing. Spatiotemporal control of microRNAs and associated protein machinery can modulate microRNA activity. Additionally, adaptive modulation of microRNA expression and function in response to changing environmental conditions ensures that robust cell fate specification during development is maintained. Herein, we review the role of microRNAs in the regulation of differentiation during development.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell fate; Development; Differentiation; MicroRNAs; Post-transcriptional gene regulation

Mesh:

Substances:

Year:  2020        PMID: 33152557     DOI: 10.1016/j.ceb.2020.08.015

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  13 in total

1.  Feedback between a retinoid-related nuclear receptor and the let-7 microRNAs controls the pace and number of molting cycles in C. elegans.

Authors:  Ruhi Patel; Himani Galagali; John K Kim; Alison R Frand
Journal:  Elife       Date:  2022-08-15       Impact factor: 8.713

2.  Spatially and Temporally Distributed Complexity-A Refreshed Framework for the Study of GRN Evolution.

Authors:  Alessandro Minelli; Alberto Valero-Gracia
Journal:  Cells       Date:  2022-05-30       Impact factor: 7.666

Review 3.  Sex Determination in Nematode Germ Cells.

Authors:  Ronald E Ellis
Journal:  Sex Dev       Date:  2022-02-16       Impact factor: 1.943

4.  Differential expression profile of plasma exosomal microRNAs in chronic rhinosinusitis with nasal polyps.

Authors:  Shuai He; Jun Wu; Demin Han; Yunchuan Li; Tong Wang; Hongzheng Wei; Yangwang Pan; Hongrui Zang
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-03

5.  miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.

Authors:  Hongliang Liao; Yaqin Liang; Lin Kang; Yun Xiao; Tao Yu; Renping Wan
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

6.  Comprehensive Analysis of microRNAs in Human Adult Erythropoiesis.

Authors:  Aneesha Nath; Janakiram Rayabaram; Smitha Ijee; Abhirup Bagchi; Anurag Dutta Chaudhury; Debanjan Roy; Karthik Chambayil; Jyoti Singh; Yukio Nakamura; Shaji R Velayudhan
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

7.  Relationship between miR-338-3p and Clinicopathological Parameters, Prognosis, and STAT3 mRNA Expression in Nasopharyngeal Carcinoma.

Authors:  Youyou Wang; Huijun Ren; Zhaohu Pan; Ben Liu; Fan Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

8.  microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3.

Authors:  Yaqin Li; Tao Zhou; Xianyi Cheng; Dezhi Li; Meng Zhao; Wei V Zheng
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

9.  LINGO-1 regulates Wnt5a signaling during neural stem and progenitor cell differentiation by modulating miR-15b-3p levels.

Authors:  Chen-Guang Zhao; Jie Qin; Jia Li; Shan Jiang; Fen Ju; Wei Sun; Zhen Ren; Yu-Qiang Ji; Rui Wang; Xiao-Long Sun; Xiang Mou; Hua Yuan
Journal:  Stem Cell Res Ther       Date:  2021-06-29       Impact factor: 6.832

10.  Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models.

Authors:  Andreia M Nunes; Monique Ramirez; Takako I Jones; Peter L Jones
Journal:  Dis Model Mech       Date:  2021-08-24       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.